---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-008370"
form_type: "8-K/A"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:40:29.918573+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TOI amends Q4/FY2022 results: net loss up $1.5M due to goodwill tax adjustment

## Summary
- Net loss for Q4 2022 increased by $1.5M; net income for FY2022 decreased by $1.5M due to tax deductible goodwill adjustment.
- Updated Q4 revenue $71M (+36.6% YoY), gross profit $16M (+87.6% YoY), net loss $11.0M.
- FY2022 ended with $132M cash; added 3 gain share contracts; market count increased to 15.
- Management: surpassed top end of revised 2022 guidance for Revenue, Gross Profit, Adjusted EBITDA.
- Remediated two material weaknesses; continues plan for complex accounting transactions.

## SEC filing metadata
- accession: 0001628280-23-008370
- form_type: 8-K/A
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000162828023008370/0001628280-23-008370-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000162828023008370/toi-20230309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-008370
- JSON: https://secwatch.observer/filing/0001628280-23-008370.json
- Plain text: https://secwatch.observer/filing/0001628280-23-008370.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. reported fourth quarter ended December 31, 2022 results: revenue $71 million, net income Net loss of $11.0 million, EPS $(0.12) and $(0.16).
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $71 million
  - Net income: Net loss of $11.0 million
  - EPS: $(0.12) and $(0.16)
  - Result: reported results
  source text: Fourth Quarter 2022 Financial Highlights • Consolidated revenue of $71 million, an increase of 36.6% from $52 million compared to the prior year quarter • Gross profit of $16 million, an increase of 87.6% compared to the prior year quarter • Net loss of $11.0 million compared to net loss of $10.2 million for the prior year quarter • Basic and diluted earnings per share of $(0.12) and $(0.16), respectively, compared to $(0.13) for the prior year quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828023008370/0001628280-23-008370-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.